Free Trial
NYSE:ENZ

Enzo Biochem Q2 2025 Earnings Report

Enzo Biochem logo
$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Enzo Biochem Revenue Results

Actual Revenue
$7.33 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Enzo Biochem Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Monday, March 17, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Enzo Biochem's Q3 2025 earnings is scheduled for Thursday, June 12, 2025, with a conference call scheduled on Friday, June 13, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Enzo Biochem Earnings Headlines

Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com
Enzo Biochem transitions to OTCQX market
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX
See More Enzo Biochem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enzo Biochem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enzo Biochem and other key companies, straight to your email.

About Enzo Biochem

Enzo Biochem (NYSE:ENZ) develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

View Enzo Biochem Profile

More Earnings Resources from MarketBeat